Literature DB >> 31786885

A novel predictor in patients with gastrointestinal stromal tumors: Systemic immune-inflammation index (SII).

Ali Yilmaz1, Cem Mirili, Mehmet Bilici, Salim Basol Tekin.   

Abstract

PURPOSE: Systemic inflammation and immune response are associated with tumors'prognosis. However, there is little information about inflammatory indexes in patients with gastrointestinal stromal tumor (GIST). In this study, we aimed to determine the prognostic significance of inflammation indexes such as neutrophil to lymphocyte ratio (NLR), systemic immune-inflammation index (SII), prognostic nutritional index (PNI) and Glasgow prognostic score (GPS) in GIST patients.
METHODS: Forty-five patients diagnosed with GIST between 2003 and 2018 were included in the study. The effects of NLR, SII, PNI and GPS on progression-free survival (PFS) and overall survival (OS) estimated based on clinicopathological and laboratory data were evaluated by Kaplan-Meier and Cox regression analysis.
RESULTS: The optimal cut-off values for NLR, SII and PNI were 2.54, 940, and 37.5, respectively. Low SII and higher PNI values were associated with longer PFS (p=0.041, p=0.018, respectively). In terms of OS, patients with high NLR, high SII and low PNI had a shorter lifespan. In multivariate analysis, only SII was found to be independent prognostic factor.
CONCLUSION: In cases with GIST, SII may predict recurrence and survival.

Entities:  

Mesh:

Year:  2019        PMID: 31786885

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  8 in total

1.  Development and validation of a prognostic nomogram to predict recurrence in high-risk gastrointestinal stromal tumour: A retrospective analysis of two independent cohorts.

Authors:  Yao Lin; Ming Wang; Jie Jia; Wenze Wan; Tao Wang; Wenchang Yang; Chengguo Li; Xin Chen; Hui Cao; Peng Zhang; Kaixiong Tao
Journal:  EBioMedicine       Date:  2020-09-25       Impact factor: 8.143

Review 2.  Prognostic Indicators for Gastrointestinal Stromal Tumors: A Review.

Authors:  Haixin Zhang; Qi Liu
Journal:  Transl Oncol       Date:  2020-06-28       Impact factor: 4.243

3.  Novel Prognostic Nomogram for Recurrence-Free Survival of Patients With Primary Gastrointestinal Stromal Tumors After Surgical Resection: Combination of Prognostic Nutritional Index and Basic Variables.

Authors:  Shuliang Li; Daming Chen; Shilong Li; Zongxian Zhao; Huaxiang Yang; DaoHan Wang; Zhaoxiong Zhang; Weihua Fu
Journal:  Front Oncol       Date:  2021-01-28       Impact factor: 6.244

4.  Prognostic Value of the Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Patients With Medulloblastoma Undergoing Surgical Resection.

Authors:  Sihan Zhu; Zhuqing Cheng; Yuanjun Hu; Zhenghe Chen; Ji Zhang; Chao Ke; Qunying Yang; Fuhua Lin; Yinsheng Chen; Jian Wang
Journal:  Front Nutr       Date:  2021-12-17

5.  Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.

Authors:  Busra Yilmaz; Efsun Somay; Ugur Selek; Erkan Topkan
Journal:  Ther Clin Risk Manag       Date:  2021-10-18       Impact factor: 2.423

6.  Naples prognostic score, a novel prognostic score for patients with high- and intermediate-risk gastrointestinal stromal tumours after surgical resection.

Authors:  Hao Wu; Mengdi Fu; Xiaozhou Xie; Jianqiao Yang; Yang Liu; Fengying Du; Zhen Fang; Liang Shang; Leping Li
Journal:  World J Surg Oncol       Date:  2022-03-01       Impact factor: 2.754

7.  Development and validation of a novel pre-operative comprehensive prognostic score in esophageal squamous cell carcinoma.

Authors:  Jifeng Feng; Liang Wang; Xun Yang; Qixun Chen
Journal:  Bosn J Basic Med Sci       Date:  2022-06-01       Impact factor: 3.759

8.  A novel quantitative prognostic model for initially diagnosed non-small cell lung cancer with brain metastases.

Authors:  Xiaohui Li; Wenshen Gu; Yijun Liu; Xiaoyan Wen; Liru Tian; Shumei Yan; Shulin Chen
Journal:  Cancer Cell Int       Date:  2022-08-11       Impact factor: 6.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.